Company: LRHC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032211
Chunk: 2834

Company: La Rosa Holdings Corp.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 9A
Chunk 2834
---
 shares with respect to which
the applicable performance period has not been completed will be paid out as soon as practicable, and all outstanding shares of restricted
stock with respect to which the restrictions have not lapsed will be deemed vested, and all such restrictions shall be deemed lapsed and
the restriction period ended.

Additionally, after the merger
of one or more corporations into the Company, any merger of the Company into another corporation, any consolidation of the Company and
one or more corporations, or any other corporate reorganization of any form involving the Company as a party thereto and involving any
exchange, conversion, adjustment or other modification of the outstanding shares of the Common Stock, each participant shall, at no additional
cost, be entitled, upon any exercise of such participant’s stock option, to receive, in lieu of the number of shares as to which
such stock option shall then be so exercised, the number and class of shares of stock or other securities or such other property to which
such participant would have been entitled to pursuant to the terms of the agreement of merger or consolidation or reorganization, if at
the time of such merger or consolidation or reorganization, such participant had been a holder of record of a number of shares of Common
Stock equal to the number of shares as to which such stock option shall then be so exercised.

Modification of Awards.
The Compensation Committee may reprice any stock option without the approval of the stockholders of the Company. For this purpose, “reprice”
means: (i) any of the following or any other action that has the same effect: (A) lowering the exercise price of a stock option after
it is granted, (B) any other action that is treated as a repricing under U.S. generally accepted accounting principles, or (C) cancelling
a stock option at a time when its exercise price exceeds the fair market value of the underlying Common Stock, in exchange for another
stock option, restricted stock or other equity, unless the cancelation and exchange occur in connection with a merger, acquisition, spin-off
or other similar corporate transaction; and (ii) any other action that is considered to be a repricing under formal or informal guidance
issued by the exchange or market on which the Company’s Common Stock then trades or is quoted. In addition to, and without limiting
the above, the Compensation Committee may permit the voluntary surrender of all or a portion of any stock option granted under the 2022
Plan to be conditioned upon the granting to the participant